{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:56:07Z","timestamp":1792155367738,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03404-8","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:59:29Z","timestamp":1776805169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Formulation-Based Repurposing of Mifepristone Using a Drug-Eluting Intrauterine Insert for Localized Uterine Fibroid Therapy: A Preclinical Study"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-0359","authenticated-orcid":false,"given":"Riya","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-5011","authenticated-orcid":false,"given":"Alkesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-1281","authenticated-orcid":false,"given":"Gayatri","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"3404_CR1","unstructured":"Steve Eisinger. Uterine fibroids | Office on Women\u2019s Health [Internet]. 2021 [cited 2022 May 3]. https:\/\/www.womenshealth.gov\/a-z-topics\/uterine-fibroids. Accessed 3 May 2022"},{"key":"3404_CR2","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/jog.14002","volume":"45","author":"MM Dolmans","year":"2019","unstructured":"Dolmans MM, Donnez J, Fellah L. Uterine fibroid management: today and tomorrow. J Obstet Gynaecol Res. 2019;45:1222\u20139. https:\/\/doi.org\/10.1111\/jog.14002.","journal-title":"J Obstet Gynaecol Res"},{"key":"3404_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13102","author":"E Giuliani","year":"2020","unstructured":"Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020. https:\/\/doi.org\/10.1002\/ijgo.13102.","journal-title":"Int J Gynaecol Obstet"},{"key":"3404_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1071-5576(00)00056-3","volume":"7","author":"CL Walker","year":"2000","unstructured":"Walker CL, Burroughs KD, Davis B, Sowell K, Everitt JI, Fuchs-Young R, et al. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma. J Soc Gynecol Investig. 2000;7:249\u201356. https:\/\/doi.org\/10.1016\/S1071-5576(00)00056-3.","journal-title":"J Soc Gynecol Investig"},{"key":"3404_CR5","unstructured":"A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy - Tabular View - ClinicalTrials.gov [Internet]. [cited 2022 May 3]. https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT03210324. Accessed 3 May 2022"},{"key":"3404_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.08.039","author":"Q Shen","year":"2013","unstructured":"Shen Q, Hua Y, Jiang W, Zhang W, Chen M, Zhu X. Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis. Fertil Steril. 2013. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.039.","journal-title":"Fertil Steril"},{"key":"3404_CR7","doi-asserted-by":"publisher","unstructured":"D\u00edaz-Castro F, Monsalves-\u00c1lvarez M, Rojo LE, del Campo A, Troncoso R. Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing\u2019s Syndrome. Front Pharmacol. Frontiers Media S.A.; 2020;11. https:\/\/doi.org\/10.3389\/FPHAR.2020.00429\/FULL","DOI":"10.3389\/FPHAR.2020.00429\/FULL"},{"key":"3404_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108649","volume":"159","author":"J Xu","year":"2020","unstructured":"Xu J, Gong XF, Li P, Chen XF, Wang HP, Ning LF. Mifepristone polymorph with enhanced solubility, dissolution and oral bioavailability. Steroids. 2020;159:108649. https:\/\/doi.org\/10.1016\/j.steroids.2020.108649.","journal-title":"Steroids"},{"key":"3404_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jddst.2018.11.023","volume":"49","author":"SS Deshkar","year":"2019","unstructured":"Deshkar SS, Palve VK, Elsevier. Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery. J Drug Deliv Sci Technol. 2019;49:277\u201385. https:\/\/doi.org\/10.1016\/j.jddst.2018.11.023.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3404_CR10","doi-asserted-by":"publisher","unstructured":"Boyd BJ, Bergstr\u00f6m CAS, Vinarov Z, Kuentz M, Brouwers J, Augustijns P, et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci. 2019;137:104967. https:\/\/doi.org\/10.1016\/j.ejps.2019.104967.","DOI":"10.1016\/j.ejps.2019.104967"},{"key":"3404_CR11","unstructured":"Oral delivery of poorly water-soluble drugs - Faculty of Pharmacy and Pharmaceutical Sciences [Internet]. [cited 2022 Jan 14]. https:\/\/www.monash.edu\/pharm\/research\/archive\/drug-delivery\/research-areas\/drug-delivery\/oral-delivery-of-poorly-water-soluble-drugs. Accessed 14 Jan 2022"},{"key":"3404_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/195727","volume":"2012","author":"KT Savjani","year":"2012","unstructured":"Savjani KT, Gajjar AK, Savjani JK, Hindawi Limited. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:1\u201310. https:\/\/doi.org\/10.5402\/2012\/195727.","journal-title":"ISRN Pharm"},{"key":"3404_CR13","unstructured":"Mishina E V., Gosh TK. Center for Drug Evaluation and Research Application Number: 22\u2013512 Clinical Pharmacology and Biopharmaceutics Review. 2010;"},{"key":"3404_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.14227\/DT300423P238","volume":"30","author":"R Patel","year":"2023","unstructured":"Patel R, Patel G. Preparation and characterization of a novel optimum modified liquisolid compact to enhance the dissolution profile of mifepristone. Dissolution Technol. 2023;30:238\u201344. https:\/\/doi.org\/10.14227\/DT300423P238.","journal-title":"Dissolution Technol"},{"key":"3404_CR15","first-page":"760","volume":"5","author":"K Verma","year":"2014","unstructured":"Verma K, Sharma PK, Dudhe R, Patro SK. Formulation. Design and Development of Mifepristone. 2014;5:760\u20139.","journal-title":"Design and Development of Mifepristone"},{"key":"3404_CR16","doi-asserted-by":"publisher","unstructured":"Zhang H, Wu F, Li Y, Yang X, Huang J, Lv T, et al. Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone. Beilstein J Nanotechnol. 2016;7:1861\u201370. https:\/\/doi.org\/10.3762\/bjnano.7.178.","DOI":"10.3762\/bjnano.7.178"},{"key":"3404_CR17","unstructured":"Margerrison E, Lucas S. Medical Device Material Performance Study Polypropylene Safety Profile Prepared for Submitted to Date of Submission. 2020;"},{"key":"3404_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12645-024-00272-4","volume":"15","author":"S Sadeghi","year":"2024","unstructured":"Sadeghi S, Mohammadnejad J, Eidi A, Jafary H, BioMed Central Ltd. Biocompatible PLGA-PCL nanobeads for efficient delivery of curcumin to lung cancer. Cancer Nanotechnol [Internet]. 2024;15:1\u201323. https:\/\/doi.org\/10.1186\/s12645-024-00272-4.","journal-title":"Cancer Nanotechnol [Internet]"},{"key":"3404_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jconrel.2020.11.008","volume":"330","author":"L Repp","year":"2021","unstructured":"Repp L, Rasoulianboroujeni M, Lee HJ, Kwon GS, Elsevier. Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection. J Control Release. 2021;330:1004\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.008.","journal-title":"J Control Release"},{"key":"3404_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.12.004","author":"MT Cook","year":"2018","unstructured":"Cook MT, Brown MB, Elsevier B.V. Polymeric gels for intravaginal drug delivery. J Control Release. 2018. https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.004.","journal-title":"J Control Release"},{"key":"3404_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/ijwh.s28103","volume":"4","author":"JL Carbonell Esteve","year":"2012","unstructured":"Carbonell Esteve JL, River\u00f3n AM, Cano M, Ortiz AI, Valle A, Texid\u00f3 CS, et al. Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery. Int J Womens Health. 2012;4:75\u201384. https:\/\/doi.org\/10.2147\/ijwh.s28103.","journal-title":"Int J Womens Health"},{"key":"3404_CR22","doi-asserted-by":"publisher","unstructured":"Liu C, Lu Q, Qu H, Geng L, Bian M, Huang M, et al. Different dosages of mifepristone versus enantone to treat uterine fibroids: a multicenter randomized controlled trial. Med. 2017. https:\/\/doi.org\/10.1097\/MD.0000000000006124.","DOI":"10.1097\/MD.0000000000006124"},{"key":"3404_CR23","doi-asserted-by":"publisher","unstructured":"Tiboni M, Campana R, Frangipani E, Casettari L. 3D printed clotrimazole intravaginal ring for the treatment of recurrent vaginal candidiasis. Ahmed Barhoum MBASHM, editor. Int J Pharm. 1st ed. Berlin, Heidelberg: Int J Pharm; 2021;596:433\u201341. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120290","DOI":"10.1016\/j.ijpharm.2021.120290"},{"key":"3404_CR24","doi-asserted-by":"publisher","unstructured":"shah S, Patel R, Patel G. Nanocomposite hydrogels: an optimistic insight towards the treatments of ocular disorders. Recent Pat Nanotechnol. 2023;17. https:\/\/doi.org\/10.2174\/1872210517666230731102130","DOI":"10.2174\/1872210517666230731102130"},{"key":"3404_CR25","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/REP-21-0087","volume":"162","author":"GW Kirschen","year":"2021","unstructured":"Kirschen GW, AlAshqar A, Miyashita-Ishiwata M, Reschke L, El Sabeh M, Borahay MA, et al. Vascular biology of uterine fibroids: connecting fibroids and vascular disorders. Reproduction [Internet]. 2021;162:R1-18. https:\/\/doi.org\/10.1530\/REP-21-0087.","journal-title":"Reproduction [Internet]"},{"key":"3404_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3897\/PHARMACIA.68.E66586","volume":"68","author":"S Albetawi","year":"2021","unstructured":"Albetawi S, Abdalhafez A, Abu-Zaid A, Matrouk A, Alhourani N, Bulgarian Pharmaceutical Scientific Society. Recent solubility and dissolution enhancement techniques for repaglinide a BCS class II drug: a review. Pharmacia. 2021;68:573\u201383. https:\/\/doi.org\/10.3897\/PHARMACIA.68.E66586.","journal-title":"Pharmacia"},{"issue":"3","key":"3404_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1590\/1980-5373-MR-2015-0797","volume":"19","author":"DC Fran\u00e7a","year":"2016","unstructured":"Fran\u00e7a DC, Bezerra EB, De Souza Morais DD, Ara\u00fajo EM, Wellen RMR. Hydrolytic and thermal degradation of PCL and PCL\/bentonite compounds. Materials Research [Internet]. 2016;19(3):618\u201327. https:\/\/doi.org\/10.1590\/1980-5373-MR-2015-0797.","journal-title":"Materials Research [Internet]"},{"key":"3404_CR28","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.xphs.2015.12.012","volume":"105","author":"J Holl\u00e4nder","year":"2016","unstructured":"Holl\u00e4nder J, Genina N, Jukarainen H, Khajeheian M, Rosling A, M\u00e4kil\u00e4 E, et al. Three-dimensional printed PCL-based implantable prototypes of medical devices for controlled drug delivery. J Pharm Sci. 2016;105:2665\u201376. https:\/\/doi.org\/10.1016\/j.xphs.2015.12.012.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3404_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jchromb.2005.12.019","volume":"832","author":"Z Guo","year":"2006","unstructured":"Guo Z, Chu C, Yin G, He M, Fu K, Wu J. An HPLC method for the determination of ng mifepristone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;832(2):181\u20134. https:\/\/doi.org\/10.1016\/j.jchromb.2005.12.019.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"3404_CR30","first-page":"185","volume":"75","author":"S Vidyadhara","year":"2013","unstructured":"Vidyadhara S, Sasidhar RLC, Nagaraju R, Wolters Kluwer - Medknow Publications. Design and development of polyethylene oxide based matrix tablets for verapamil hydrochloride. Indian J Pharm Sci. 2013;75:185\u201390.","journal-title":"Indian J Pharm Sci"},{"key":"3404_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104552","volume":"84","author":"R Patel","year":"2023","unstructured":"Patel R, Shah R, Patel A, Hadiya K, Parmar J, Patel G, et al. Off-label use of Raloxifene hydrochloride in uterine fibroids: a novel insert-based formulation approach and IN-VIVO preclinical evaluation. J Drug Deliv Sci Technol. 2023;84:104552. https:\/\/doi.org\/10.1016\/j.jddst.2023.104552.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3404_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/md17120692","author":"M Szekalska","year":"2019","unstructured":"Szekalska M, Wr\u00f3blewska M, Trofimiuk M, Basa A, Winnicka K, Multidisciplinary Digital Publishing Institute (MDPI). Alginate oligosaccharides affect mechanical properties and antifungal activity of alginate buccal films with posaconazole. Mar Drugs. 2019. https:\/\/doi.org\/10.3390\/md17120692.","journal-title":"Mar Drugs"},{"key":"3404_CR33","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1080\/10717544.2016.1177137","volume":"23","author":"A Patel","year":"2016","unstructured":"Patel A, Tyagi A, Sharma RK, Thakkar H. A gamma scintigraphy study to investigate uterine targeting efficiency of raloxifene-loaded liposomes administered intravaginally in New Zealand white female rabbits. Drug Deliv. 2016;23:3330\u20138. https:\/\/doi.org\/10.1080\/10717544.2016.1177137.","journal-title":"Drug Deliv"},{"key":"3404_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.polymdegradstab.2020.109275","author":"N Poursharifi","year":"2020","unstructured":"Poursharifi N, Semnani D, Soltani P, Amanpour S, Elsevier Ltd. Designing a novel and versatile multi-layered nanofibrous structure loaded with MTX and 5-FU for the targeted delivery of anticancer drugs. Polym Degrad Stab. 2020. https:\/\/doi.org\/10.1016\/j.polymdegradstab.2020.109275.","journal-title":"Polym Degrad Stab"},{"key":"3404_CR35","doi-asserted-by":"publisher","unstructured":"Patel G, Patel P, Sonara Z, Patel R, Pharm ( M. Fabrication and Optimization of 3D Printed Insert Coated With Rate Controlling Membrane in the Treatment of Recurrent Vaginal Candidiasis Via Vaginal Route. https:\/\/doi.org\/10.2139\/SSRN.4514316","DOI":"10.2139\/SSRN.4514316"},{"key":"3404_CR36","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.31838\/ijpr\/2021.13.03.121","volume":"10","author":"S Jagtap","year":"2018","unstructured":"Jagtap S, Magdum C, Jadge D, Jagtap R. Solubility enhancement technique: a review. J Pharm Sci Res. 2018;10:2205\u201311. https:\/\/doi.org\/10.31838\/ijpr\/2021.13.03.121.","journal-title":"J Pharm Sci Res"},{"key":"3404_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121255","author":"JH Lee","year":"2021","unstructured":"Lee JH, Park C, Weon KY, Kang CY, Lee BJ, Park JB, et al. Improved bioavailability of poorly water-soluble drug by targeting increased absorption through solubility enhancement and precipitation inhibition. Pharmaceuticals. 2021. https:\/\/doi.org\/10.3390\/ph14121255.","journal-title":"Pharmaceuticals"},{"key":"3404_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/649030","volume":"2013","author":"JL Carbonell","year":"2013","unstructured":"Carbonell JL, Acosta R, P\u00e9rez Y, Garc\u00e9s R, S\u00e1nchez C, Tomasi G, et al. Treatment of uterine myoma with 2.5 or 5 mg mifepristone daily during 3 months with 9 months posttreatment followup: randomized clinical trial. ISRN Obstet Gynecol. 2013;2013:1\u20138. https:\/\/doi.org\/10.1155\/2013\/649030.","journal-title":"ISRN Obstet Gynecol"},{"key":"3404_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1158\/ajc.1940.185","volume":"39","author":"A Lipschutz","year":"1940","unstructured":"Lipschutz A, Vargas L, Jedlicky A, Bellolio P, American Association for Cancer Research. The minimum quantity of estrogen required to induce atypical epithelial growth of the uterine mucosa in the guinea-pig. Am J Cancer. 1940;39:185\u201398. https:\/\/doi.org\/10.1158\/ajc.1940.185.","journal-title":"Am J Cancer"},{"key":"3404_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2460\/ajvr.80.7.657","volume":"80","author":"TJ Oura","year":"2019","unstructured":"Oura TJ, Graham JE, Knafo SE, Aarsvold S, Gladden JN, Barton BA, et al. Evaluation of gastrointestinal activity in healthy rabbits by means of duplex Doppler ultrasonography. Am J Vet Res. 2019;80:657\u201362. https:\/\/doi.org\/10.2460\/ajvr.80.7.657.","journal-title":"Am J Vet Res"},{"key":"3404_CR41","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1039\/d3tb01250f","volume":"11","author":"YL Cai","year":"2023","unstructured":"Cai YL, Nan F, Tang GT, Ma Y, Ren Y, Xiong XZ, et al. Fabrication of 3D printed PCL\/PEG artificial bile ducts as supportive scaffolds to promote regeneration of extrahepatic bile ducts in a canine biliary defect model. J Mater Chem B. 2023;11:9443\u201358. https:\/\/doi.org\/10.1039\/d3tb01250f.","journal-title":"J Mater Chem B"},{"key":"3404_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0885328214528256","volume":"29","author":"M Pathak","year":"2014","unstructured":"Pathak M, Turner M, Palmer C, Coombes AGA. Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis. J Biomater Appl. 2014;29:354\u201363. https:\/\/doi.org\/10.1177\/0885328214528256.","journal-title":"J Biomater Appl"},{"key":"3404_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104469","volume":"84","author":"S Moroni","year":"2023","unstructured":"Moroni S, Bischi F, Aluigi A, Campana R, Tiboni M, Casettari L. 3D printing fabrication of Ethylene-Vinyl Acetate (EVA) based intravaginal rings for antifungal therapy. J Drug Deliv Sci Technol. 2023;84:104469. https:\/\/doi.org\/10.1016\/j.jddst.2023.104469.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3404_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1055\/a-1369-9395","volume":"81","author":"F Rafiei","year":"2021","unstructured":"Rafiei F, Tabesh H, Farzad S, Farzaneh F, Rezaei M, Hosseinzade F, et al. Development of hormonal intravaginal rings: technology and challenges. Geburtshilfe Frauenheilkd. 2021;81:789\u2013806. https:\/\/doi.org\/10.1055\/a-1369-9395.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"3404_CR45","unstructured":"Repurposing Drugs | National Center for Advancing Translational Sciences [Internet]. 2020 [cited 2023 May 18]. https:\/\/ncats.nih.gov\/preclinical\/repurpose. Accessed 18 May 2023"},{"key":"3404_CR46","unstructured":"Harsha Agarwal SI. Drug Repurposing: Advantages and Key Approaches [Internet]. Drug discovery from technology networks. 2021 [cited 2023 May 18]. p. 21\u20135. https:\/\/www.technologynetworks.com\/drug-discovery\/articles\/drug-repurposing-advantages-and-key-approaches-344261. Accessed 18 May 2023"},{"issue":"1","key":"3404_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018;18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat Rev Drug Discov"},{"key":"3404_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/1735-3327.92960","volume":"9","author":"B Thomas","year":"2012","unstructured":"Thomas B, Bhat K, Mapara M. Rabbit as an animal model for experimental research. Dent Res J (Isfahan). 2012;9:111. https:\/\/doi.org\/10.4103\/1735-3327.92960.","journal-title":"Dent Res J (Isfahan)"},{"key":"3404_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/humupd\/5.4.365","volume":"5","author":"E Cicinelli","year":"1999","unstructured":"Cicinelli E, De Ziegler D. Transvaginal progesterone: evidence for a new functional \u201cportal system\u201d flowing from the vagina to the uterus. Hum Reprod Update. 1999;5:365\u201372. https:\/\/doi.org\/10.1093\/humupd\/5.4.365.","journal-title":"Hum Reprod Update"},{"key":"3404_CR50","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/jpp\/rgab003","volume":"73","author":"A Patel","year":"2021","unstructured":"Patel A, Dhande R, Thakkar H. Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and leuprolide acetate as a potential carrier for uterine targeting. J Pharm Pharmacol. 2021;73:653\u201363. https:\/\/doi.org\/10.1093\/jpp\/rgab003.","journal-title":"J Pharm Pharmacol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03404-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:08:29Z","timestamp":1780502909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03404-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3404"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03404-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed (Protocol no: RPCP\/IAEC\/2021\u201322\/R11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"During the preparation of this work, the author(s) used Quill Bot, ChatGPT and Grammarly SERVICE in order to improve scientific writing and the English language. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted Technologies in the Writing Process"}},{"value":"The authors report no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"187"}}